Thimerosal: Contact (non)allergen of the year

American Journal of Contact Dermatitis

Volumn 13, Issue 1, 2002, Pages 1-2

  Belsito, Donald V ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACITRACIN; BRONOPOL; DIAZOLIDINYL UREA; ETHYLENE; FORMALDEHYDE; GLUCOCORTICOID; IMIDAZOLINE DERIVATIVE; MELAMINE; THIOMERSAL; UREA; VACCINE;

CONTACT DERMATITIS; DISEASE SEVERITY; EDITORIAL; HUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SCREENING TEST; SENSITIZATION; VACCINATION;

EID: 0036198612     PISSN: 1046199X     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajcd.2002.31366     Document Type: Editorial

References (11)

1. North American Contact Dermatitis Group patch-test results, 1996-1998
2. The European standard series
3. The importance of including thimerosal, an increasingly frequent allergen in Europe, in standard screening series for allergic contact dermatitis
4. Thimerosal in the detection of clinically relevant allergic contact reactions
5. Thiomersal hypersensitivity and vaccination
6. A probable role for vaccines containing thimerosal in thimerosal hypersensitivity
7. Patch tests reactions in children, adults and the elderly
8. Allergic contact dermatitis in children
9. Sensitization to thiomersal and previous vaccination
10. Vaccination despite thimerosal sensitivity
11. Thimerosal allergy and vaccination reactions